Cyberonics brings SEC filings up to date
This article was originally published in The Gray Sheet
Executive Summary
Maker of VNS Therapy implant for treatment-resistant epilepsy and depression files delinquent financial records with the Securities & Exchange Commission, becoming current with the Feb. 9 submission of a "10-Q" for the fiscal quarter ended Oct. 27, 2006. The firm's stock had been threatened with delisting from the Nasdaq exchange due to tardy financial filings, which resulted from an internal audit of stock option grant practices. Although the internal review concluded in November, inquiries by the SEC and U.S. Attorney's Office for the Southern District of New York are ongoing (1"The Gray Sheet" Nov. 27, 2006, p. 6)...